Phage Biotechnology Corp Company Profile

01:57 EDT 18th March 2018 | BioPortfolio

Phage Biotechnology Corporation (Phage) is a Delaware Corporation, incorporated in 1998 and headquartered in Las Vegas, Nevada. The company has a manufacturing plant in Irvine, California, with research and development laboratories in Kiev, Ukraine. Currently Phage has approximately 75 employees worldwide. The Company was initially formed to manufacture recombinant protein pharmaceuticals as “generic” drugs. This initial focus has been expanded to also include the development of new pegylated forms of existing drugs, as well as single chain antibody pharmaceuticals to treat cancer, arthritis, and auto-immune diseases.
Phage is a biopharmaceutical corporation which manufactures protein pharmaceuticals. The protein pharmaceuticals fall into three main classes, including 1) “bio-similar” versions of marketed drugs whose patents have expired, 2) new drug candidates developed by Phage that will undergo clinical trials, including longer-acting versions of marketed protein products, and 3) a new class of biopharmaceuticals, Single Chain Antibodies, that will compete with monoclonal antibodies for the treatment of cancer, arthritis, and autoimmune diseases. Utilizing a proprietary process, recombinant proteins can be produced with a unique combination of plasmid and bacteriophage technologies. This technology is being applied to the production of key protein pharmaceuticals, with multi-billion dollar estimated market values. Phage plans to manufacture and sell these protein products on a worldwide basis.
As a result of this production advantage, Phage is targeting the production and sale of drugs that no longer have patent protection. It is anticipated that the primary method for developing sales will be to offer buyers of these types of drugs a substantial price discount compared to all other pharmaceutical producers. It is estimated that Phage can discount its sales price for these drugs from between 30% to 50% of the sales price other companies are charging for the identical drugs. Even marketing these drugs at discounted levels will provide Phage with significant profit margins, in large part as a result of the minimal costs associated with manufacturing these drugs utilizing the Phage system. In addition to developing biopharmaceuticals whose patents have expired, Phage is also developing new pegylated versions of these drugs that should substantially increase the marketplace for these drugs. Most protein drugs must be injected, some daily, but pegylated versions of these drugs often go to once-weekly injections due to their much expanded half-life in the body’s circulation.


1635 Village Center CircleSuite 240
Las Vegas
United States of America


Phone: 702/492-6694
Fax: 702/492-9903

News Articles [200 Associated News Articles listed on BioPortfolio]

A patient’s legacy: Researchers work to make phage therapy less of a long shot

Inspired by the story of Mallory Smith, a biology grad student and a tech consultant launched a website to make experimental phage therapy more practical.

Biotech raises funds to help produce phage therapies for bacterial infections

Biotechnology company, Pherecydes Pharma, has raised €8.7 million in a Series B round of funding, which it plans to use to support the production of phages for compassionate use in accordance with g...

Bacteria-Killing Viruses Could Stop You From Getting Food Poisoning

A group of Finnish scientists has demonstrated that phage could be used to prevent food poisoning by killing dangerous foodborne pathogens like Yersinia enterocolitica. Researchers at the University o...

C3J Therapeutics Bolsters Antimicrobial R&D Program; Acquires Engineered Bacteriophage Assets from Synthetic Genomics

C3J Therapeutics, Inc., (C3J) a private biotechnology company focused on the development of novel targeted antimicrobials, and Synthetic Genomics, Inc., (SGI) a leader in d...

Helix BioPharma Corp. Announces Management Change

RICHMOND HILL, ONTARIO -- (Marketwired) -- 12/01/17 -- Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), an immuno-oncology company developing drug candidates for the prevention and treatment of ca...

Phage Therapy Enters New Phase

(MedPage Today) -- Researchers work to put bacteria-killing viruses into routine clinical arsenal

AmpliPhi: Advancing Bacteriophage For The Treatment Of Bacterial Infections

AmpliPhi Biosciences (NYSEMKT: APHB) is a biotechnology company focused on the development of a pipeline of naturally occurring viruses called bacteriophages, the natural predators of bacteria. Phages...

IONTAS to Generate Antibodies using Mammalian Display Technology for a Global Biopharma

IONTAS to generate antibodies with favourable, binding and expression properties using their Mammalian Display Antibody Discovery Platform IONTAS Limited (IONTAS), a leader in...

PubMed Articles [406 Associated PubMed Articles listed on BioPortfolio]

A guard-killer phage cocktail effectively lyses the host and inhibits the development of phage-resistant strains of Escherichia coli.

In recent years, after the emergence of a large number of multidrug-resistant bacteria, phages and phage-associated products for the prevention and control of bacterial disease have revealed prominent...

Contemporary Phage Biology: From Classic Models to New Insights.

Bacteriophages, discovered about a century ago, have been pivotal as models for understanding the fundamental principles of molecular biology. While interest in phage biology declined after the phage ...

Bypassing bacterial infection in phage display by sequencing DNA released from phage particles.

Phage display relies on a bacterial infection step in which the phage particles are replicated to perform multiple affinity selection rounds and to enable the identification of isolated clones by DNA ...

In Vivo Studies on the Influence of Bacteriophage Preparations on the Autoimmune Inflammatory Process.

Phage preparations used for phage therapy may have not only direct antibacterial action but also immunomodulating effects mediated by phages themselves as well as by bacterial antigens. Therefore phag...

Engineered Phage Matrix Stiffness-Modulating Osteogenic Differentiation.

Herein, we demonstrate an engineered phage mediated matrix for osteogenic differentiation with controlled stiffness by crosslinking the engineered phage displaying RGD and HPQ with various concentrati...

Clinical Trials [16 Associated Clinical Trials listed on BioPortfolio]

Evaluation and Detection of Facial Propionibacterium Acnes Bacteria and Phage

This multi-center, outpatient study will extract and evaluate the presence of facial P. acnes bacteria and phage strains using pore strips on up to 400 human subjects.

A Pilot Scheme - Specimen Collection of Health Management Center

Biomedical and biotechnology industry is internationally regarded as the most brilliant star performer of the future. The development of biomedical depends on a high quality academic resea...

Ascending Dose Study of the Safety of AB-SA01 When Topically Applied to Intact Skin of Healthy Adults

This study will examine the safety of ascending doses of AB-SA01 when topically applied to intact skin of healthy adults.

Phage II Trial of Stathmin as Predictive Biomarker for TPF Induction Chemotherapy in OSCC

To investigate the predictive value of stathmin expression as a predictive biomarker in OSCC patients, who treated with TPF (docetaxel, cisplatin and 5-fluorouracil ) induction chemotherap...

Bacteriophages for Treating Urinary Tract Infections in Patients Undergoing Transurethral Resection of the Prostate: A Randomized, Placebo-controlled, Double-blind Clinical Trial

Urinary tract infections are among the most prevalent microbial diseases and their financial burden on society is substantial. The use of bacteriophages against bacterial pathogens has gai...

Companies [933 Associated Companies listed on BioPortfolio]

Phage Biotechnology Corp

Phage Biotechnology Corporation (Phage) is a Delaware Corporation, incorporated in 1998 and headquartered in Las Vegas, Nevada. The company has a manufacturing plant in Irvine, California, with resear...

Vincogen Corporation

Vincogen Corporation is a RF ID Biochip company established in year 2000 and has developed a proprietary radio-frequency (RF) biochip platform and T4 Phage Display platforms for use in several applica...

Special Phage Services

Few inventions in science and medicine have had such a profound effect on human health as the discovery and subsequent development of antibiotics. Following their introduction during World War II ma...

Phage Biotech Ltd.

Phage-Biotech Ltd. was incorporated in March 2000, as a new player in the emerging field of Phage Therapy. The Company’s mission is to develop proprietary Phage-based anti-infective therapeutics to ...

Adaptive Phage Therapeutics, Inc.

More Information about "Phage Biotechnology Corp" on BioPortfolio

We have published hundreds of Phage Biotechnology Corp news stories on BioPortfolio along with dozens of Phage Biotechnology Corp Clinical Trials and PubMed Articles about Phage Biotechnology Corp for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Phage Biotechnology Corp Companies in our database. You can also find out about relevant Phage Biotechnology Corp Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Corporate Database Quicklinks

Searches Linking to this Company Record